Enhancement of HIV-1-induced syncytium formation in T cells by the tyrosyl kinase p56(lck)

Virology

Volumn 231, Issue 1, 1997, Pages 10-19

  Briand, Guylaine ^a   Barbeau, Benoît ^a   Corbeil, Jacques ^b,c   Tremblay, Michel ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROTEIN TYROSINE KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031011467     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8518     Document Type: Article

References (59)

1. Abraham N., Micelli M. C., Parnes J. R., Veillette A. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine kinase, p56lck. Nature. 350:1991;62-66.
2. Anderson P., Blue M. L., Morimoto C., Schlossman S. F. Cross-linking of T3(CD3) with T4(CD4) enhances the proliferation of resting T lymphocytes. J. Immunol. 139:1987;678-682.
3. Ansotegui I. J. S., Chow C., Jeddi-Tehrani M., Meloche S., Pawson A., Sékaly R.-P., Mak T. W., Wigzell H. Characterization of a monoclonal antibody directed against the phosphotyrosine kinase p56lck, in human T cells. Scand. J. Immunol. 33:1991;375-380.
4. Aoki N., Shioda T., Satoh H., Shibuta H. Syncytium formation of human and non-human cells by recombinant vaccinia viruses carrying the HIVenv. AIDS. 5:1991;871-875.
5. Ashorn P. A., Berger E. A., Moss B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64:1990;2149-2156.
6. Bernier R., Tremblay M. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J. Virol. 69:1995;291-300.
7. Bérubé P., Barbeau B., Cantin R., Sékaly R.-P., Tremblay M. Repression of human immunodeficiency virus type 1 LTR-driven gene expression by the binding of the virus to its primary cellular receptor, the CD4 molecule. J. Virol. 70:1996;4009-4016.
8. Boucher C. A. B., Lange J. M. A., Miedema F. F., Weverling G. J., Koot M., Mulder J. W., Goudsmit J., Kellam P., Larder B. A., Tersmette M. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS. 6:1992;1259-1264.
9. Burgess K. E., Odysseos A. D., Zalvan C., Drucker B. J., Anderson P., Schlossman S. F., Rudd C. E. Biochemical identification of a direct physical interaction between the CD4 :p56lck and Ti(TCR) z chain/CD3 complex and protein-tyrosine kinase. Eur. J. Immunol. 21:1991;1663-1672.
10. Cohen D. I., Tani Y., Tian H., Boone E., Samelson L., Lane H. C. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science. 256:1992;542-545.
11. Dalgleish A. G., Beverly P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
12. Doyle C., Strominger J. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 330:1987;256-259.
13. Dustin M. L., Springer T. A. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 341:1989;619-624.
14. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 362:1993;359-362.
15. Emmrich F., Strittmatter U., Eichmann K. Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen. Proc. Natl. Acad. Sci. USA. 83:1986;8298-8302.
16. Fahey J. L., Prince H., Weaver M., Groopman J., Visscher B., Schwartz K., Detels R. Quantitative changes in T helper T suppressor/cytotoxic lymphocyte subset that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am. J. Med. 76:1984;95-100.
17. Gay D. P., Maddon P. J., Sékaly R.-P., Talle A., Godfrey M., Long E., Goldstein G., Chess L., Axel R., Kappler J., Marrack P. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 328:1987;626-629.
18. Glaichenhaus N., Shastri N., Littman D. R., Turner J. M. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 64:1991;511-520.
19. Goldsmith M. A., Weiss A. Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc. Natl. Acad. Sci. USA. 84:1987;6879-6883.
20. Gottlieb M. S., Schroff R., Schanker H. M., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305:1981;1425-1431.
21. Harada S., Koyanagi Y., Yamamoto N. Infection of HTLV-III/LAV in HTLV-I carrying MT-2 and MT-4 and application in a plaque assay. Science. 229:1985;563-566.
22. James E. K., Orentas R. J. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science. 244:1989;1075-1078.
23. Karlsson A., Parsmyr K., Sandström E., Fenyö E. M., Albert J. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32:1994;364-370.
24. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J. C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
25. Koga Y., Oh-Hori N., Sato H., Yamamoto N., Kimura G., Nomoto K. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines. J. Immunol. 142:1989;4493-4499.
26. Koot M., Keet I. P. M., Vos A. H. V., De Goede R. E. Y., Roos M. T. L., Coutinho R., Miedema F., Schellekens P. T. A., Tersmette M. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118:1993;681-688.
27. Koot M., Vos A. H. V., Keet R. P. M., De Goede R. E. Y., Dercksen M. W., Terpstra F. G., Coutinho R., Miedema F., Tersmette M. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS. 6:1992;49-54.
28. Lasky L., Nakamura G., Smith D. H., Fernie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunoeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 50:1987;975-985.
29. Levy J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:1993;183-289.
30. Lifson J. D., Reyes G. R., McGrath M. S., Stein B. S., Engleman E. G. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen. Science. 232:1986;1123-1127.
31. Littman D. R. The structure of the CD4 and CD8 genes. Annu. Rev. Immunol. 5:1987;561-584.
32. Luo K. X., Sefton B. M. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine kinase at the autophosphorylation site. Mol. Cell. Biol. 10:1990;5305-5313.
33. Maddon P. J., Littman D. R., Godfrey M., Maddon D. E., Chess L., Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family. Cell. 42:1985;93-104.
34. Masur H., Michelis M. A., Greene J. B., Onorato I., Stouwe R. A., Holzman R. S., Wormser G., Brettman L., Lange M., Murray H. W., Cunningham-Rundles S. An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfuntion. N. Engl. J. Med. 305:1981;1431-1438.
35. +. Science. 231:1986;382-385.
36. Mohagheghpour N., Chakrabarti R., Stein B. S., Gowda S. D., Engleman E. G. Early activation events render T cells susceptible of HIV-1-induced syncytia formation. J. Biol. Chem. 266:1991;7233-7238.
37. Moir S., Perreault J., Poulin L. Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4. J. Virol. 70:1996;8019-9028.
38. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362:1993a;355-358.
39. Pantaleo G., Graziosi C., Fauci A. S. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:1993b;327-335.
40. Parnes J. R. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:1989;265-311.
41. Pelchen-Matthews A., Armes J. A., Griffiths G., Marsh M. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J. Exp. Med. 173:1991;575-587.
42. lck. J. Cell Biol. 117:1992;279-290.
43. 2+. J. Immunol. 147:1991;3145-3148.
44. Peterson A., Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell. 54:1988;65-72.
45. Reed L. J., Muench H. A. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:1938;493-497.
46. Reinherz E. L., Meuer S. C., Schlossman S. F. The human T cell receptor: Analysis with cytotoxic T cell clones. Immunol. Rev. 74:1983;83-112.
47. Rudd C. E. CD4, CD8 and the TCR-CD3 complex: A novel class of protein-tyrosine kinase receptor. Immunol. Today. 11:1990;400-406.
48. Rudd C. E., Anderson P., Morimoto C., Streuli M., Schlossman S. F. Molecular interactions, T-cell subsets and a role of the CD4/CD8: p56lck complex in human T-cell activation. Immunol. Rev. 111:1989;225-266.
49. Schellekens P. T. A., Tersmette M., Roos M. T. L., Keet R. P., De Wolf F., Coutinho R. A., Miedema F. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates wih HIV-1 phenotype. AIDS. 6:1992;665-669.
50. Shaw A. S., Chalupny J., Whitney J. A., Hammond C., Amrein K. E., Kavathas P., Sefton B. M., Rose J. K. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase. Mol. Cell. Biol. 10:1990;1853-1862.
51. Slater T. F., Sawyer B., Strauli U. Studies on succinate-tetrazolium reductase systems. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta. 77:1963;383-393.
52. Sleckman B. P., Peterson A., Jones W. K., Foran J. A., Greenstein J. L., Seed B., Burakoff S. J. Expression and function of CD4 in a murine T-cell hybridoma. Nature. 328:1987;351-353.
53. Straus D. B., Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor 585-593. Cell. 70:1992;585-593.
54. Straus D. B., Chan A. C., Patai B., Weiss A. SH2 domain function is essential for the role of the lck tyrosine kinase in T cell receptor signal transduction. J. Biol. Chem. 271:1996;9976-9981.
55. Tersmette M. J., Lange J. M. A., De Goede R. E. Y., De Wolf F., Eeftink-Schattenkerk J. K. M., Schellekens P. T. A., Coutinho R. A., Huisman J. G., Goudsmit J., Miedema F. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet. I:1989;983-985.
56. Todd B. J., Kedar P., Hope J. H. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells. J. Virology. 69:1995;7099-7105.
57. Weiss R. A. How does HIV cause AIDS? Nature. 260:1993;1274-1278.
58. Xu H., Littman D. R. A kinase-independent function of lck in potentiating antigen-specific T cell activation. Cell. 74:1993;633-643.
59. Yoshida H., Koga Y., Moroi Y., Kimura G., Nomoto K. The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein. Int. Immunol. 4:1992;233-242.